An update from Plus Therapeutics Inc (PSTV) is now available.
Marc Hedrick, CEO of Plus Therapeutics, recently presented at a JonesResearch webcast, with the recording now accessible on the company’s website. The presentation slides, important for understanding the company’s current status and future plans, are also available and will be used in forthcoming discussions with investors and analysts. These materials offer valuable insights but are not considered formal filings under securities law.
For an in-depth examination of PSTV stock, go to TipRanks’ Stock Analysis page.
